Midjourney says its body scanner could cut deaths 30%: what's real, what's hype

On 17 June 2026, at an event in San Francisco, Midjourney, the company famous for generating images from text, announced something nobody predicted: a medical division, Midjourney Medical, and a whole-body ultrasound scanner. The pitch: step onto a platform, descend slowly into water, pass through a ring of ultrasound sensors, and get a 3D map of your body in about a minute, without radiation. And a promise: "We think it's completely possible that with enough early imaging in the future, the world could avoid 30 percent of all deaths and 50 percent of all healthcare costs" (quoted by Engadget).

An image-generation company with no medical track record, making one of the boldest health claims in tech, deserves scrutiny rather than a hot take. This article was first published on 17 June 2026 and revised on 17 October 2026: every figure is now tied to a filing or a dated report, and the technical specifications that circulated without a verifiable source have been removed. The short version: the partnership behind the scanner is real and shows up in a public company's revenue; the death-reduction claim runs against the stated position of the FDA and of radiologists.

What Midjourney announced

The product is the Midjourney Scanner. The technique is ultrasound computed tomography: the body is immersed in water for acoustic coupling, a ring of sensors emits ultrasound and records the echoes, and software reconstructs a 3D map. No ionising radiation, no strong magnetic field. What was said on and around 17 June:

Element	What was announced	Source
Scan time	About 60 seconds as a goal; Midjourney compares it with 60 to 90 minutes for a full-body MRI	The Next Web, 18 June 2026; Engadget
Sensors	A ring that Midjourney describes as "half a million squares the size of a grain of sand"; 40 Butterfly "ultrasound-on-chip" modules per machine	Engadget; The Next Web
Detail	A 3D map "down to a fraction of a millimeter", no numeric resolution published	Engadget
What it does today	Detailed body composition maps only; no FDA clearance; diagnostic use would require FDA approval	The Next Web; Engadget
Next 12 months	Research trials and a second-generation hardware design	Engadget
2028	Third-generation machine with custom silicon	Engadget
End of 2027	A "Midjourney Spa" of about 25,000 sq ft near Union Square, San Francisco, with nine or ten scanners, hot tubs, saunas and cold plunges	The Next Web
2031	More than 50,000 scanners worldwide and capacity for "a billion scans a month"	The Next Web
Price	Not disclosed; David Holz declined to say what a scan will cost	The Next Web

Two quotes from founder David Holz frame it. To Bloomberg: "We're not even using any AI in this yet, just really cool hardware and software." And on performance: "in many ways superior to even MRI machines" (both reported by The Next Web). The project is led by Tom Calloway PhD, Head of Medical at Midjourney, according to a correction published by Engadget.

Note what is not there: no published resolution figure, no peer-reviewed study, no independent measurement of the machine. Reports even disagree on the sensor count: "half a million" in Midjourney's own description, a ring of 8,960 transducers in a Spanish-language report of 19 June. Until Midjourney publishes data, every specification is a company claim.

The partnership is real, and it shows up in revenue

This is what separates the project from vaporware. The scanner is built on a partnership with Butterfly Network (NYSE: BFLY), the "ultrasound-on-chip" company, disclosed to the SEC:

• On 17 November 2025, Butterfly entered a Co-Development and Licensing Agreement with Midjourney, granting it an exclusive license, within a specified field of use, to its ultrasound-on-chip technology. Midjourney pays a one-time fee of 15 million dollars and a 10 million dollar annual license fee, plus up to 9 million dollars of milestone payments, revenue sharing on hardware products and payments for chips, over a five-year term (Form 8-K). That is up to 74 million dollars in fixed fees and milestones over five years, by our sum, before revenue share and chips.
• In the first quarter of 2026, Butterfly's US revenue rose 25% to 21.4 million dollars, "primarily driven by revenue from our Butterfly Embedded partnerships, including our co-development partnership with Midjourney" (results of 30 April 2026), weeks before the public reveal.
• In the second quarter, US revenue rose 57% to 27.6 million dollars, with the same explanation (results of 30 July 2026).

Whatever you make of the vision, there is real money moving through a public company's books. That is the strongest fact in the story, and the reason the claims around it deserve more scrutiny, not less.

What ultrasound tomography has proven so far

Ultrasound tomography is not new, but its clinical use is narrow. In October 2021, the FDA approved Delphinus's SoftVue, a 3D whole-breast ultrasound tomography system, as an adjunct to mammography for screening women with dense breasts (AuntMinnie). The breast is a favourable case: small, easy to immerse, with no bone, lung or gas in the way of sound. Imaging a whole body, through ribs, lungs and gut, is a much harder physics problem, and we found no whole-body ultrasound tomography system with FDA clearance at the time of Midjourney's announcement.

The spa, and the regulatory question

The scanner is not arriving in a hospital. It is arriving in a spa, next to saunas and cold plunges. That is also a regulatory choice: by producing body composition maps and making no diagnostic claims, the device can sit on the wellness side of the line, while diagnostic capabilities wait for FDA approval. It is clever framing. It also means that, at launch, the machine is not allowed to tell you that you are sick, which sits awkwardly next to a promise to cut deaths by 30 percent.

The 30% claim, against the medical position

Does scanning healthy people save lives at scale? The authorities that have looked at whole-body screening are not on Midjourney's side.

• The FDA says it "knows of no scientific evidence demonstrating that whole-body scanning of individuals without symptoms" provides more benefit than harm, and warns that "false" leads can prompt further, unnecessary testing (FDA, page on full-body CT scans).
• The American College of Radiology, on 17 April 2023, said it does not believe the evidence is sufficient to recommend total body screening for people without symptoms, risk factors or family history, citing incidental findings that lead to extra tests and procedures (ACR statement).

One fair point for Midjourney: the FDA's strongest warnings target CT, whose radiation is harmful in itself, and ultrasound has none. But the deeper problem, overdiagnosis, does not depend on the technology: scan enough healthy bodies and you find many harmless anomalies, each of which can trigger anxiety, more tests and procedures with their own risks. Midjourney published no data to support the 30 percent figure; the company's own wording makes it a possibility "in the future", not a result.

Midjourney is not alone in this bet. Neko Health, co-founded by Spotify's Daniel Ek, raised 260 million dollars at a 1.8 billion dollar valuation in January 2025 to expand its body-scanning clinics to the US (Bloomberg, 23 January 2025), and whole-body MRI screening services are spreading, as the RSNA noted in July 2026.

Who is making the claim

Some context on the company sharpens the picture. Midjourney is known for its image models, not for medical devices. And there is an irony worth naming: on 11 June 2025, Disney and Universal, with Marvel, Lucasfilm and DreamWorks among the co-plaintiffs, sued Midjourney for copyright infringement in the US District Court for the Central District of California, over how its models were trained and what they produce (NBC News). A company sued over how it used other people's images now asks the public to trust it with images of the inside of their bodies. The vision is exciting; the track record invites caution.

Our take: how to read an announcement like this

What follows is our analysis.

Midjourney is exceptional at one thing: producing a compelling image. This announcement applies that skill to a narrative. The trap is to react to the image instead of the evidence. The discipline is to sort each claim into three buckets:

• Verified. The Butterfly agreement, its fees and its effect on Butterfly's revenue, all in SEC filings. A radiation-free technique with a clinical precedent in the breast.
• Announced, unproven. A full-body scan in 60 seconds, a spa at the end of 2027, custom silicon in 2028, 50,000 scanners and a billion scans a month by 2031. Targets, not results.
• Unsupported. "30 percent of all deaths and 50 percent of all healthcare costs" avoided: no published data, and the FDA and the American College of Radiology say the evidence for screening people without symptoms is not there.

That sorting is not cynicism, it is literacy. When the most advanced technology companies are also the best storytellers, telling a verified fact from a beautiful projection is a core skill, for an investor, a patient or a business. It is the same discipline we apply to the tools we choose for our own products. For more on that summer's AI wave, read our pieces on SpaceX buying Cursor and Seedance 2.5.